Who is sponsoring NCT03696927?

NCT03696927 is sponsored by AbiliTech Medical Inc..

What condition does NCT03696927 study?

NCT03696927 studies Spinal Cord Injuries.

Is NCT03696927 still recruiting?

NCT03696927 is currently completed. Last updated 15 November 2022.

Are results published for NCT03696927?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-11-15 · How we verify

NCT03696927

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Active Powered Prosthesis (APEX) for Spinal Cord Injury

Completed NA Results posted Last updated 15 November 2022

What this trial tests

NA trial testing Active Powered Prosthesis (APEX) for Spinal Cord Injury in Spinal Cord Injuries in 4 participants. Completed in 29 August 2018.

Timeline

29 August 2018

Primary endpoint
29 August 2018

29 August 2018

Quick facts

Lead sponsor	AbiliTech Medical Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	4
Start date	29 August 2018
Primary completion	29 August 2018
Estimated completion	29 August 2018
Sites	1 location across United States

Drugs / interventions tested

Active Powered Prosthesis (APEX) for Spinal Cord Injury

Conditions studied

Spinal Cord Injuries — all drugs for Spinal Cord Injuries →

Sponsor

AbiliTech Medical Inc.

Who can join

18 and older, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

User Ability to Operate the APEX Device Primary · Two hours of in-clinic prototype evaluation

Users evaluate the usability and performance of the APEX device in completion of Activities of Daily Living (ADLs).

Change Device Modes using Voice Control

Group	Value	95% CI
User Focus Group Participants	4

Control Device to Mimic ADL Performance on Manikin

Group	Value	95% CI
User Focus Group Participants	4

Sponsor's own description

The Active Powered Prosthesis (APEX) (AbiliTech Medical Inc., Minneapolis, MN) is a proof-of-concept shoulder-elbow-wrist device intended to provide non-invasive active powered robotic assistive movement to upper extremities. The objective of this study is to perform focus groups with users and clinicians to evaluate a proof of concept active powered assistance device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

NCT07109804 — Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury · NA · recruiting
NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
NCT07210411 — Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury · NA · recruiting
NCT07488793 — Remote Ischemic Conditioning for PwSCI · NA · recruiting
NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting

Other AbiliTech Medical Inc. trials

Trials by the same sponsor.

NCT05409079 — Schulze Muscular Dystrophy Ability Clinical Study · NA · unknown
NCT04308447 — Ablelite Pediatric Device Clinical Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03696927 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AbiliTech Medical Inc.
Last refreshed: 15 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03696927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing